The Program for Neurology Research & Discovery is now an affiliated program of the Michigan Institute for Clinical and Health Research (MICHR).
As part of the agreement, the Program will have access to MICHR’s clinical research support, including the Michigan Clinical Research Unit, which supports human tests of new treatments and medications, as well as its biorepository, educational programs and more.
“Adding the Program for Neurology Research & Discovery to MICHR’s affiliations and alliances is beneficial to each of the constituencies we serve, and I am very pleased that we are bringing together our collective expertise and resources,” said Ken Pienta, M.D. and MICHR Director.
“As we continue to look for ways to enable and enhance clinical and health research, partnering with excellent programs like Eva Feldman’s Program for Neurology Research & Discovery help accelerate the pace of scientific discovery at U-M.”
Dr. Feldman, M.D., Ph.D, the Director of the Program for Neurology Research & Discovery, is equally excited about the new collaboration.
“We are so pleased to be working with MICHR, whose mission and ideals we share,” she said. “It will help provide the resources we need to quicken the pace of turning our research into new treatments for our patients.”
MICHR seeks to enable and enhance the positive impact of clinical and translational research at the University of Michigan, and to make U-M a world leader in translating scientific discoveries into real health gains.